|
Valproic Acid Delayed or Extended-Release or Sprinkle Capsule
|
|
Depakote Delayed-Release Capsule; Depakote ER Extended-Release Capsule; Depakote Sprinkle Capsule; Divalproex Sodium
|
Valproic Acid Delayed or Extended-Releas... Clinical Trials
- Compliance With Once-Daily Divalproex Extended-Release Tablets (Depakote-ER) Versus Multiple-Daily Dose Valproic Acid Capsules (Depakene) in Epilepsy:
ClinicalTrials.gov Identifier: NCT00356018 - Not yet recruiting
Epilepsy
- Evaluate Efficacy and Safety of Tolterodine Extended Release Capsule Compared with Tolterodine Immediate Release Tablet in Patients with Symptoms of Overactive Bladder
ClinicalTrials.gov Identifier: NCT00139724 - Completed
Overactive bladder
- Study Evaluating LAMICTAL Extended-release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
ClinicalTrials.gov Identifier: NCT00113165 - Active, not recruiting
Epilepsy
- Randomized Phase Iii-Study On Valproic Acid In Combination With All-Trans Retinoic Acid, Standard Induction- And Consolidation Therapy In Older Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00151255 - Recruiting
Acute myeloid leukemia, age > 60 years
- Randomized Phase Ii-Study On Valproic Acid, All-Trans Retinoic Acid And Their Combination In Induction And Consolidation Therapy As Well As Pegfilgrastim After Consolidation Therapy In Younger Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov Identifier: NCT00151242 - Recruiting
Acute Myeloid Leukemia
- Valproic Acid in Treating Patients With Kaposi's Sarcoma
ClinicalTrials.gov Identifier: NCT00075777 - Active, not recruiting
recurrent Kaposi's sarcoma; epidemic Kaposi's sarcoma
- Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors
ClinicalTrials.gov Identifier: NCT00107458 - Active, not recruiting
childhood brain tumor; childhood meningioma; childhood solid tumor; childhood spinal cord tumors
- A Study to Evaluate LAMICTAL Extended-release Therapy in Patients with Primary Generalized Tonic Clonic Seizures
ClinicalTrials.gov Identifier: NCT00104416 - Active, not recruiting
Tonic-Clonic Seizures; Epilepsy
- PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS
ClinicalTrials.gov Identifier: NCT00439673 - Active, not recruiting
Myelodysplastic Syndromes
- RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole
ClinicalTrials.gov Identifier: NCT00314860 - Active, not recruiting
Restless Legs Syndrome
- Comparison of Acid Reflux at Two Levels in the Esophagus Using the BRAVO Capsule
ClinicalTrials.gov Identifier: NCT00579410 - Active, not recruiting
Esophagitis; Inflammation; Gastritis; Abdominal Pain; Heartburn
- Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00084981 - Active, not recruiting
recurrent non-small cell lung cancer; stage IV non-small cell lung cancer
- Azacytidine With Valproic Acid Versus Ara-C in AML/MDS Patients
ClinicalTrials.gov Identifier: NCT00382590 - Active, not recruiting
Acute Myelogenous Leukemia; Myelodysplastic Syndrome; Leukemia
- Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor Malignancies
ClinicalTrials.gov Identifier: NCT00246103 - Recruiting
Neoplams, Advanced
- The Effects of Valproic Acid on Zidovudine Glucuronidation and Pharmacokinetics in HIV-Infected Patients.
ClinicalTrials.gov Identifier: NCT00000629 - Completed
HIV Infections
- To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With High Cholesterol.
ClinicalTrials.gov Identifier: NCT00271817 - Recruiting
Hypercholesterolemia
- Decitabine With or Without Valproic Acid in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00109824 - Recruiting
recurrent adult Burkitt's lymphoma; recurrent adult diffuse large cell lymphoma; recurrent mantle cell lymphoma
- Pharmacokinetics of Immediate-Release vs. Delayed-Release Omeprazole in Gastroparesis
ClinicalTrials.gov Identifier: NCT00492622 - Recruiting
Gastroparesis; Gastroesophageal Reflux Disease
- Comparing Compliance, Tolerability, Efficacy and Adverse Events in Bipolar Tients From Valproic Acid to Depakote ER.
ClinicalTrials.gov Identifier: NCT00211250 - Recruiting
Mood Disorder
- Valproic Acid, Temozolomide, and Radiation Therapy in Treating Patients With Glioblastoma Multiforme
ClinicalTrials.gov Identifier: NCT00313664 - Recruiting
Brain and Central Nervous System Tumors
- A Within-Subject Cross-Over Comparison Between Immediate Release and Extended Release Adderall
ClinicalTrials.gov Identifier: NCT00468143 - Not yet recruiting
Attention Deficit Hyperactivity Disorder
- Decitabine and Valproic Acid in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov Identifier: NCT00079378 - Recruiting
adult acute myeloid leukemia; refractory chronic lymphocytic leukemia; Small Lymphocytic Lymphoma
- Tolerability of MK0524A Versus Niacin Extended-Release
ClinicalTrials.gov Identifier: NCT00378833 - Active, not recruiting
Hypercholesterolemia; Hyperlipidemia
- Study of Valproic Acid to Treat HIV Infected Adults
ClinicalTrials.gov Identifier: NCT00312546 - Recruiting
HIV Infections
- Phase I/II Trial of Valproic Acid and Karenitecin for Melanoma
ClinicalTrials.gov Identifier: NCT00358319 - Recruiting
Malignant Melanoma
- Valproic Acid and Its Effects on HIV Latent Reservoirs
ClinicalTrials.gov Identifier: NCT00289952 - Recruiting
HIV Infections
- Valproic Acid (Depakote ER) in Patients With Advanced Thyroid Cancer
ClinicalTrials.gov Identifier: NCT00525135 - Recruiting
Head and Neck Cancer
- Effect of an Investigational Compound on Tolerability of Extended Release Niacin
ClinicalTrials.gov Identifier: NCT00376584 - Active, not recruiting
Hypercholesteremia; Hyperlipidemia
- Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor
ClinicalTrials.gov Identifier: NCT00495872 - Recruiting
Advanced Cancer
- Azacytidine and Valproic Acid in Patients With Advanced Cancers
ClinicalTrials.gov Identifier: NCT00496444 - Active, not recruiting
Advanced Cancers
- Capsule Endoscopic Miss Rates Determined by Back-to-Back Capsule Endoscopy
ClinicalTrials.gov Identifier: NCT00530231 - Recruiting
Capsule Endoscopy
- Study Evaluating Venlafaxine Extended Release in Elderly Depressed Patients
ClinicalTrials.gov Identifier: NCT00247429 - Active, not recruiting
Depressive Syndrome; Anxiety
- Phase II Study of Valproic Acid With FEC100 for Patients With Locally Advanced Breast Cancer
ClinicalTrials.gov Identifier: NCT00437801 - Recruiting
Breast Cancer
- Phase I Study of Temazolomide, Valproic Acid and Radiation Therapy in Subjects With Brain Metastases
ClinicalTrials.gov Identifier: NCT00437957 - Recruiting
Unresectable Brain Metastases
- Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma
ClinicalTrials.gov Identifier: NCT00181220 - Recruiting
Nasopharyngeal Carcinoma
- Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy
ClinicalTrials.gov Identifier: NCT00227266 - Active, not recruiting
Spinal Muscular Atrophy
- 5-Azacytidine Valproic Acid and ATRA in AML and High Risk MDS
ClinicalTrials.gov Identifier: NCT00339196 - Recruiting
Acute Myelogenous Leukaemia (AML); Myelodysplastic Syndrome (MDS)
- Azacitidine and Valproic Acid Plus Carboplatin in Patients With Platinum Resistant Epithelial Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00529022 - Recruiting
Advanced Cancer; Ovarian Cancer
- Valproic Acid and Bevacizumab in Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00530907 - Recruiting
Advanced Cancer
- Pioglitazone Vs Placebo in Combination With Niacin Extended Release on Low HDL
ClinicalTrials.gov Identifier: NCT00300365 - Recruiting
Metabolic Syndrome
- Study of Extended Release Niacin/Laropiprant on Lipids
ClinicalTrials.gov Identifier: NCT00479388 - Recruiting
Primary Hypercholesterolemia; Mixed Dyslipidemia
- Randomized Placebo-Controlled Trial of Valproic Acid in Patients With Progressive Supranuclear Palsy
ClinicalTrials.gov Identifier: NCT00385710 - Recruiting
Progressive Supranuclear Palsy (PSP)
- Open Label Study of Lithium Plus Extended-Release Carbamazepine (ERC-CBZ) for Rapid Cycling Bipolar Disorder
ClinicalTrials.gov Identifier: NCT00325286 - Active, not recruiting
Bipolar Disorder
- Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy
ClinicalTrials.gov Identifier: NCT00355082 - Active, not recruiting
Epilepsy, Partial
- A Study to Evaluate the Efficacy and Safety of Three Fixed Doses of Extended-Release Paliperidone in Subjects With Bipolar I Disorder
ClinicalTrials.gov Identifier: NCT00299715 - Active, not recruiting
Bipolar Disorder; Mood Disorders
- A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis
ClinicalTrials.gov Identifier: NCT00541658 - Recruiting
Postmenopausal Osteoporosis
- PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes
ClinicalTrials.gov Identifier: NCT00153062 - Active, not recruiting
Cerebrovascular Accident
- Study to Measure the Safety of Paliperidone ER (Extended-Release) in Patients With Liver Disease
ClinicalTrials.gov Identifier: NCT00535145 - Recruiting
Schizophrenia; Psychotic Disorders; Schizoaffective Disorder
- 3 Fixed Dosages of Extended Release OROS Paliperidone and Olanzapine in the Treatment of Subjects with Schizophrenia
ClinicalTrials.gov Identifier: NCT00078039 - Active, not recruiting
Schizophrenia
- Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women
ClinicalTrials.gov Identifier: NCT00511953 - Active, not recruiting
Hot Flashes
- Extended Release OROS Paliperidone in Treatment of Schizophrenia (double blind, placebo-controlled trial, with Olanzapine arm)
ClinicalTrials.gov Identifier: NCT00083668 - Active, not recruiting
Schizophrenia
- Valproic Acid in Ambulant Adults With Spinal Muscular Atrophy
ClinicalTrials.gov Identifier: NCT00481013 - Recruiting
Spinal Muscular Atrophy
- Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on Atherosclerosis
ClinicalTrials.gov Identifier: NCT00397657 - Recruiting
Atherosclerosis
- Lamotrigine Extended-Release in Elderly Patients With Epilepsy
ClinicalTrials.gov Identifier: NCT00516139 - Recruiting
Epilepsy
- Improving Hispanic Retention in Antidepressant Therapy
ClinicalTrials.gov Identifier: NCT00057642 - Active, not recruiting
Depression; Depressive Disorder
- A Study of the Efficacy and Safety of One Dosage of Paliperidone Extended Release (ER) in Treating Patients With Schizophrenia
ClinicalTrials.gov Identifier: NCT00524043 - Recruiting
Schizophrenia
- Study to Evaluate Symptoms in Patients Treated With Nebivolol or Metoprolol Extended-Release (ER) for Hypertension
ClinicalTrials.gov Identifier: NCT00547300 - Recruiting
Hypertension
- Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00348309 - Recruiting
Alzheimer Disease
- A Trial to Explore the Tolerability, Safety and Effectiveness of Paliperidone ER (Extended Release) Flexible Dosing in Patients With Schizophrenia
ClinicalTrials.gov Identifier: NCT00460512 - Recruiting
Schizophrenia
- Peg-Intron/Ribavirin in G 1 HCV for Non-Extended Versus 24 Week Extended Treatment After 24 Weeks (Study P04144AM)
ClinicalTrials.gov Identifier: NCT00202839 - Active, not recruiting
Hepatitis C, Chronic
- Safety/Efficacy of Letrozole Monotherapy or in Combination With Zoledronic Acid as Extended Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer
ClinicalTrials.gov Identifier: NCT00332709 - Recruiting
Osteoporosis, Postmenopausal
- Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia
ClinicalTrials.gov Identifier: NCT00315900 - Recruiting
Agitation; Dementia
- A Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Paliperidone Extended Release (ER) in the Treatment of Schizophrenia in Adolescent Patients.
ClinicalTrials.gov Identifier: NCT00518323 - Recruiting
Schizophrenia
- Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study
ClinicalTrials.gov Identifier: NCT00088452 - Active, not recruiting
Childhood Absence Epilepsy; Petit Mal Epilepsy; Epilepsy; Seizures
- A Study to Evaluate the Efficacy and Safety of Adjustable Doses of Extended-Release (ER) Paliperidone Compared With Placebo, in Combination With Lithium or Valproate, to Treat Manic and Mixed Episodes in Patients With Bipolar I Disorder
ClinicalTrials.gov Identifier: NCT00309686 - Active, not recruiting
Affective Psychosis, Bipolar; Bipolar Disorder; Mania
- A Trial to Explore the Tolerability, Safety and Treatment Response of the Antipsychotic Paliperidone ER (Extended Release) Using Flexible Dosing in Patients With Acute Schizophrenia
ClinicalTrials.gov Identifier: NCT00566631 - Recruiting
Schizophrenia
- A Study to Evaluate the Efficacy and Safety of Flexible Doses of Extended-Release (ER) Paliperidone Compared With Flexible Doses of Quetiapine and Placebo in Patients With Bipolar I Disorder
ClinicalTrials.gov Identifier: NCT00309699 - Active, not recruiting
Bipolar Disorder; Mood Disorders
- Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00348140 - Recruiting
Alzheimer's Disease
- Rosiglitazone (Extended Release Tablets) Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00428090 - Recruiting
Alzheimer's Disease
- HDAC Inhibitor Valproic Acid as an Effective Therapy for Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00524667 - Not yet recruiting
Chronic Lymphocytic Leukemia
- Exercise vs. Extended-Release Niacin in Patients With Coronary Heart Disease and Low HDL Cholesterol: Effect on Lipid Profile and Endothelial Function
ClinicalTrials.gov Identifier: NCT00298909 - Recruiting
Coronary Disease; Hypolipoproteinemia
- Open-Label Study of Flexible-Dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.
ClinicalTrials.gov Identifier: NCT00488319 - Recruiting
Dementia Praecox.; Schizophrenia; Psychotic Disorders; Schizophrenic Disorders
- An Open-Label Extension Study With Flexible Dosing of Extended-Release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic Pain
ClinicalTrials.gov Identifier: NCT00487435 - Recruiting
Low Back Pain; Pain; Osteoarthritis
- YSPSL for Prevention of Delayed Graft Function Part A
ClinicalTrials.gov Identifier: NCT00298181 - Active, not recruiting
Delayed Graft Function
- Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
ClinicalTrials.gov Identifier: NCT00264615 - Completed
Epilepsy
- Pilot Study on the Effect of Oral Controlled-Release Alpha-Lipoic Acid on Oxidative Stress in Adolescents With Type 1 Diabetes Mellitus
ClinicalTrials.gov Identifier: NCT00187564 - Active, not recruiting
Diabetes Mellitus, Type 1
- Evaluation of Effectiveness and Safety of Flexible-Dose Paliperidone Extended Release in Patients With Schizoaffective Disorder.
ClinicalTrials.gov Identifier: NCT00412373 - Recruiting
Psychotic Disorder; Schizoaffective Disorder
- Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder.
ClinicalTrials.gov Identifier: NCT00397033 - Recruiting
Schizoaffective Disorder; Psychotic Disorder
- Carbamazepine Extended-Release for the Treatment of Bipolar Depression
ClinicalTrials.gov Identifier: NCT00203567 - Recruiting
Bipolar Depression
- APC-231 Once a Day (QD) for 7 days vs. Pencillin taken Four Times a Day (QID) in Pediatric Patients with Strep Throat
ClinicalTrials.gov Identifier: NCT00100126 - Completed
Pharyngitis
- Extended Release Nifedipine Treatment as Maintenance Tocolysis to Prevent Preterm Delivery
ClinicalTrials.gov Identifier: NCT00525486 - Not yet recruiting
Preterm Labor
- A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Low Back Pain
ClinicalTrials.gov Identifier: NCT00449176 - Recruiting
Low Back Pain
- A Phase III Trial to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee
ClinicalTrials.gov Identifier: NCT00421928 - Recruiting
Pain; Osteoarthritis, Knee
- Effect of Procrit(Epoetin Alfa) on Preventing Delayed Graft Function After Deceased Donor Renal Transplantation
ClinicalTrials.gov Identifier: NCT00425126 - Recruiting
Delayed Graft Function
- A Safety and Efficacy Study for Tapentadol (CG5503) Extended Release for Patients With Painful Diabetic Peripheral Neuropathy
ClinicalTrials.gov Identifier: NCT00455520 - Recruiting
Diabetic Polyneuropathy; Diabetic Neuropathy: Painful
- Study Investigating a Delayed-Release Pancrelipase in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
ClinicalTrials.gov Identifier: NCT00510484 - Not yet recruiting
Cystic Fibrosis
- Phase I/II Study of Decitabine and Valproic Acid in Relapsed/Refractory Leukemia or Myelodysplastic Syndromes
ClinicalTrials.gov Identifier: NCT00075010 - Terminated
Leukemia; Myelodysplastic Syndromes
- Activity of Essential Fatty Acid Elongation/Desaturation Pathway During Early Life in Human Infants, In Vivo
ClinicalTrials.gov Identifier: NCT00342303 - Active, not recruiting
Fatty Acid Metabolism
- A study to compare the efficacy of intravenous loading doses followed by maintenance treatment with oral ibandronic acid versus zoledronic acid in patients with skeletal metastases experiencing moderate to severe pain.
ClinicalTrials.gov Identifier: NCT00099177 - Active, not recruiting
Pain; Bone Neoplasms; Neoplasm Metastasis
- A Study to Evaluate the Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Delaying the Recurrence of Symptoms in Bipolar I Disorder
ClinicalTrials.gov Identifier: NCT00490971 - Recruiting
Manic-Depressive Psychosis; Affective Disorder, Bipolar; Bipolar Disorder; Depression, Bipolar; Manic Disorder
- Enoximone Plus Extended-Release Metoprolol Succinate in Subjects with Advanced Chronic Heart Failure
ClinicalTrials.gov Identifier: NCT00077948 - Active, not recruiting
Heart Failure, Congestive
- Synchronization and Desynchronization Between Circadian Rhythms in Patients With Delayed Sleep Phase Syndrome (DSPS)
ClinicalTrials.gov Identifier: NCT00282061 - Recruiting
Delayed Sleep Phase Syndrome
- A Study To Assess The Pharmacokinetics Of SB-742457 Formulated As A Capsule And A Tablet In Healthy Elderly Volunteers.
ClinicalTrials.gov Identifier: NCT00551772 - Active, not recruiting
Alzheimer Disease
- A study to compare the efficacy of intravenous loading doses followed by maintenance treatment with intravenous ibandronic acid versus zoledronic acid in patients with skeletal metastases experiencing moderate to severe pain.
ClinicalTrials.gov Identifier: NCT00099203 - Active, not recruiting
Pain; Bone Neoplasms; Neoplasm Metastasis
- A Randomized Trial of Immediate Versus Delayed Initiation of Oral Contraceptive Pills After Abortion
ClinicalTrials.gov Identifier: NCT00235534 - Active, not recruiting
Abortion; Randomized; Contraception; Pregnancy
- Relationship Between Folic Acid and Warfarin Metabolism and Effect
ClinicalTrials.gov Identifier: NCT00162409 - Recruiting
Folic Acid Deficiency
- Effect of Niacin Extended Release and Lovastatin tablets on Walking in Patients with Intermittent Claudication (ICPOP)
ClinicalTrials.gov Identifier: NCT00062556 - Completed
Intermittent Claudication; Peripheral Vascular Disease
- Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects during the Maintenance Phase of Bipolar Illness
ClinicalTrials.gov Identifier: NCT00071253 - Terminated
Bipolar Disorder
- A Study to Look at the Efficacy and Safety of Keppra® Extended Release
ClinicalTrials.gov Identifier: NCT00368069 - Completed
Epilepsy
- DHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's Disease
ClinicalTrials.gov Identifier: NCT00440050 - Active, not recruiting
Alzheimer's Disease
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
